This post was originally published on this site
https://i-invdn-com.investing.com/trkd-images/LYNXMPEJ1M0FF_L.jpg
The company said it does not expect the move to impact its full-year 2023 forecast.
It now expects first-quarter earnings to represent about 33% of full-year 2023 adjusted earnings per share, compared with 35% estimated previously.
Humana also anticipated a roughly 30 basis points increase in its medical cost ratio, a percentage of its spends on claims to the premiums it collects, for the first quarter.
It however, expects, an impact on the medical cost ratio for the full year.
